hepatitis B

News

GSK hails 'unprecedented' cure rates with hep B drug

The B-Well trials of GSK's bepirovirsen position the antisense drug as a "major step towards a cure for hepatitis B infection," according to experts.

News

GSK enlists local aid for Chinese rollout of hep B drug

GSK has partnered Sino Biopharm to make the most of the Chinese launch of hepatitis B drug bepirovirsen, currently under NMPA review.

News

GSK eyes October FDA verdict on chronic hep B drug

GSK's antisense-based drug for chronic hepatitis B (CHB), bepirovirsen, has started a speedy FDA review that should deliver a verdict by 26th October.

News

GSK preps filings for chronic hepatitis B drug bepirovirsen

GSK will file its chronic hepatitis B virus therapy bepirovirsen for approval in the first quarter, after it hit the mark in two phase 3 trials.

News

Acting CDC director and former tech investor Jim O'Neill

CDC signs off on advice ending universal hepatitis B jabs

Overturning decades of advice, the CDC has said it no longer recommends that all US newborns receive a hepatitis B vaccine.

News

CDC panel votes to scrap hepatitis B birth dose advice

CDC advisers vote to overturn decades of US policy and abandon endorsement of universal hepatitis B vaccination for newborns in the US.

GSK hails 'unprecedented' cure rates with hep B drug

GSK enlists local aid for Chinese rollout of hep B drug

GSK eyes October FDA verdict on chronic hep B drug

GSK preps filings for chronic hepatitis B drug bepirovirsen

CDC signs off on advice ending universal hepatitis B jabs

CDC panel votes to scrap hepatitis B birth dose advice

Lundbeck preps for key bexicaserin data around year-end

Discover a new era of healthcare panel engagement: Grounded ...

hepatitis B

Editor's Picks